Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types

Recruiting now

Conditions studied: Diagnosis of Cancer of Various Organs

In brief

ClearNote Health is developing a test from whole blood for the early detection of multiple cancers. The goal of this study is to employ genomics, epigenomics and proteomics methodology for the detection of cancer signal in the blood of subjects with solid tumors.

Key facts

Study ID
NCT03869814
Run by
ClearNote Health
People needed
20000
Starts
2018-04-05
Expected to finish
2029-09-13
Last updated by the study team
2026-05-15

Who can join

Age: 21 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.